| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| HIMSHims & Hers Health, Inc. | 6.85B | 31.23 | 58.92 | 69.33% | 6.05% | 23.03% | 2.9% | 0.02 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 82.56M | 148.76M | 271.88M | 526.92M | 872M | 1.48B |
| Revenue Growth % | - | 0.8% | 0.83% | 0.94% | 0.65% | 0.69% |
| Cost of Goods Sold | 37.95M | 39.31M | 67.38M | 118.19M | 157.05M | 303.38M |
| COGS % of Revenue | 0.46% | 0.26% | 0.25% | 0.22% | 0.18% | 0.21% |
| Gross Profit | 44.6M | 109.45M | 204.49M | 408.72M | 714.95M | 1.17B |
| Gross Margin % | 0.54% | 0.74% | 0.75% | 0.78% | 0.82% | 0.79% |
| Gross Profit Growth % | - | 1.45% | 0.87% | 1% | 0.75% | 0.64% |
| Operating Expenses | 119.02M | 124.59M | 319.54M | 477.42M | 744.4M | 1.11B |
| OpEx % of Revenue | 1.44% | 0.84% | 1.18% | 0.91% | 0.85% | 0.75% |
| Selling, General & Admin | 119.02M | 113.36M | 249.56M | 370.78M | 576.32M | 846.61M |
| SG&A % of Revenue | 1.44% | 0.76% | 0.92% | 0.7% | 0.66% | 0.57% |
| Research & Development | 0 | 11.24M | 22.38M | 29.24M | 48.23M | 78.82M |
| R&D % of Revenue | - | 0.08% | 0.08% | 0.06% | 0.06% | 0.05% |
| Other Operating Expenses | 0 | 0 | 47.59M | 77.4M | 119.86M | 185.8M |
| Operating Income | -74.41M | -15.14M | -115.04M | -68.7M | -29.45M | 61.9M |
| Operating Margin % | -0.9% | -0.1% | -0.42% | -0.13% | -0.03% | 0.04% |
| Operating Income Growth % | - | 0.8% | -6.6% | 0.4% | 0.57% | 3.1% |
| EBITDA | -74.15M | -14.09M | -110.97M | -61.22M | -19.94M | 78.99M |
| EBITDA Margin % | -0.9% | -0.09% | -0.41% | -0.12% | -0.02% | 0.05% |
| EBITDA Growth % | - | 0.81% | -6.88% | 0.45% | 0.67% | 4.96% |
| D&A (Non-Cash Add-back) | 260K | 1.06M | 4.08M | 7.47M | 9.52M | 17.09M |
| EBIT | -71.61M | -15.14M | -115.04M | -68.7M | -29.45M | 61.9M |
| Net Interest Income | -369K | -10K | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 369K | 10K | 0 | 0 | 0 | 0 |
| Other Income/Expense | 2.44M | -2.84M | 4.25M | 2.99M | 7.88M | 9.81M |
| Pretax Income | -71.97M | -17.99M | -110.8M | -65.71M | -21.57M | 71.71M |
| Pretax Margin % | -0.87% | -0.12% | -0.41% | -0.12% | -0.02% | 0.05% |
| Income Tax | 90K | 127K | -3.14M | -31K | 1.98M | -54.33M |
| Effective Tax Rate % | 1% | 1.01% | 0.97% | 1% | 1.09% | 1.76% |
| Net Income | -72.06M | -18.11M | -107.66M | -65.68M | -23.55M | 126.04M |
| Net Margin % | -0.87% | -0.12% | -0.4% | -0.12% | -0.03% | 0.09% |
| Net Income Growth % | - | 0.75% | -4.94% | 0.39% | 0.64% | 6.35% |
| Net Income (Continuing) | -72.06M | -18.11M | -107.66M | -65.68M | -23.55M | 126.04M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.07 | -0.51 | -0.58 | -0.32 | -0.11 | 0.53 |
| EPS Growth % | - | 0.75% | -0.14% | 0.45% | 0.66% | 5.82% |
| EPS (Basic) | -2.07 | -0.51 | -0.58 | -0.32 | -0.11 | 0.58 |
| Diluted Shares Outstanding | 34.76M | 35.35M | 186.78M | 204.52M | 209.34M | 236.81M |
| Basic Shares Outstanding | 34.76M | 35.35M | 186.78M | 204.52M | 209.34M | 215.94M |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 69.61M | 113.08M | 269.9M | 216.59M | 265.05M | 395.83M |
| Cash & Short-Term Investments | 60.37M | 100.21M | 247.27M | 179.63M | 220.98M | 300.25M |
| Cash Only | 22.65M | 27.34M | 71.78M | 46.77M | 96.66M | 220.58M |
| Short-Term Investments | 37.72M | 72.86M | 175.49M | 132.85M | 124.32M | 79.67M |
| Accounts Receivable | 859K | 750K | 3.58M | 3.23M | 6.75M | 6.08M |
| Days Sales Outstanding | 3.8 | 1.84 | 4.8 | 2.24 | 2.82 | 1.5 |
| Inventory | 4.22M | 3.54M | 13.56M | 21.56M | 22.46M | 64.43M |
| Days Inventory Outstanding | 40.56 | 32.9 | 73.44 | 66.59 | 52.21 | 77.51 |
| Other Current Assets | 480K | 5.89M | 890K | 1.78M | 4.2M | 8.9M |
| Total Non-Current Assets | 2.46M | 5.61M | 150.68M | 149.75M | 176.13M | 311.71M |
| Property, Plant & Equipment | 0 | 0 | 5.11M | 16.14M | 45.73M | 92.96M |
| Fixed Asset Turnover | - | - | 53.19x | 32.66x | 19.07x | 15.88x |
| Goodwill | 0 | 0 | 110.88M | 110.88M | 110.88M | 112.73M |
| Intangible Assets | 0 | 59K | 25.89M | 21.84M | 18.57M | 43.41M |
| Long-Term Investments | 0 | 204.53M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2.46M | -198.97M | 8.8M | 889K | 947K | 1M |
| Total Assets | 72.07M | 118.7M | 420.58M | 366.34M | 441.19M | 707.54M |
| Asset Turnover | 1.15x | 1.25x | 0.65x | 1.44x | 1.98x | 2.09x |
| Asset Growth % | - | 0.65% | 2.54% | -0.13% | 0.2% | 0.6% |
| Total Current Liabilities | 20.62M | 15.23M | 79.22M | 47.94M | 88.47M | 221.37M |
| Accounts Payable | 7.23M | 8.07M | 19.64M | 32.36M | 43.07M | 91.18M |
| Days Payables Outstanding | 69.54 | 74.9 | 106.38 | 99.94 | 100.1 | 109.7 |
| Short-Term Debt | 1.51M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 753K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 9.1M | 1.57M | 0 | 0 | 0 | 0 |
| Current Ratio | 3.38x | 7.43x | 3.41x | 4.52x | 3.00x | 1.79x |
| Quick Ratio | 3.17x | 7.19x | 3.24x | 4.07x | 2.74x | 1.50x |
| Cash Conversion Cycle | -25.19 | -40.16 | -28.14 | -31.12 | -45.07 | -30.68 |
| Total Non-Current Liabilities | 186.74M | 250.34M | 6.75M | 6.66M | 8.69M | 9.46M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 4.12M | 3.65M | 8.67M | 9.46M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 186.74M | 250.34M | 2.63M | 3.01M | 22K | 0 |
| Total Liabilities | 207.36M | 265.57M | 85.97M | 54.6M | 97.16M | 230.82M |
| Total Debt | 1.51M | 0 | 5.48M | 5.31M | 9.95M | 11.35M |
| Net Debt | -21.13M | -27.34M | -66.3M | -41.47M | -86.72M | -209.24M |
| Debt / Equity | - | - | 0.02x | 0.02x | 0.03x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | 0.14x |
| Net Debt / EBITDA | - | - | - | - | - | -2.65x |
| Interest Coverage | -201.66x | -1514.40x | - | - | - | - |
| Total Equity | -135.29M | -146.87M | 334.62M | 311.74M | 344.03M | 476.72M |
| Equity Growth % | - | -0.09% | 3.28% | -0.07% | 0.1% | 0.39% |
| Book Value per Share | -3.89 | -4.15 | 1.79 | 1.52 | 1.64 | 2.01 |
| Total Shareholders' Equity | -135.29M | -146.87M | 334.62M | 311.74M | 344.03M | 476.72M |
| Common Stock | 4.5M | 5K | 20K | 21K | 21K | 22K |
| Retained Earnings | -153.18M | -171.29M | -278.95M | -344.63M | -368.18M | -242.14M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 2K | -11K | -137K | -277K | -124K | -324K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | -74.87M | -2.48M | -34.41M | -26.53M | 73.48M | 251.08M |
| Operating CF Margin % | -0.91% | -0.02% | -0.13% | -0.05% | 0.08% | 0.17% |
| Operating CF Growth % | - | 0.97% | -12.88% | 0.23% | 3.77% | 2.42% |
| Net Income | -72.06M | -18.11M | -107.66M | -65.68M | -23.55M | 126.04M |
| Depreciation & Amortization | 260K | 1.06M | 4.08M | 7.47M | 9.52M | 17.09M |
| Stock-Based Compensation | 8.03M | 5.83M | 67.21M | 42.82M | 66.08M | 92.32M |
| Deferred Taxes | 0 | 0 | -3.39M | -594K | -13K | -61.65M |
| Other Non-Cash Items | -1.24M | 4.56M | 1.89M | 3.65M | 626K | -1.34M |
| Working Capital Changes | -9.85M | 4.19M | 3.46M | -14.2M | 20.82M | 78.62M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -522K | 674K | -9.63M | -8M | -902K | -41.61M |
| Change in Payables | -6.08M | 826K | 9.85M | 12.72M | 7.32M | 43.71M |
| Cash from Investing | -39.3M | -39.7M | -156.27M | 34.7M | -12.11M | -19.05M |
| Capital Expenditures | -308K | -1.74M | -832K | -2.71M | -17.22M | -41.66M |
| CapEx % of Revenue | 0% | 0.01% | 0% | 0.01% | 0.02% | 0.03% |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | -1.48M | -2.5M | -4.17M | -4.53M | -9.27M | -11.1M |
| Cash from Financing | 95.32M | 47.74M | 235.04M | -33.13M | -11.47M | -107.84M |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | -333K | -2.64M | -16.81M | -33.13M | -9.48M | -24.81M |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | -76.65M | -6.71M | -39.42M | -33.78M | 46.99M | 198.33M |
| FCF Margin % | -0.93% | -0.05% | -0.14% | -0.06% | 0.05% | 0.13% |
| FCF Growth % | - | 0.91% | -4.87% | 0.14% | 2.39% | 3.22% |
| FCF per Share | -2.21 | -0.19 | -0.21 | -0.17 | 0.22 | 0.84 |
| FCF Conversion (FCF/Net Income) | 1.04x | 0.14x | 0.32x | 0.40x | -3.12x | 1.99x |
| Interest Paid | 361K | 10K | 0 | 0 | 0 | 0 |
| Taxes Paid | 139K | 221K | 338K | 636K | 1.11M | 7.92M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -114.69% | -20.32% | -7.18% | 30.71% |
| Return on Invested Capital (ROIC) | - | - | -183.38% | -19.13% | -8.37% | 17.69% |
| Gross Margin | 54.03% | 73.58% | 75.22% | 77.57% | 81.99% | 79.45% |
| Net Margin | -87.29% | -12.18% | -39.6% | -12.46% | -2.7% | 8.54% |
| Debt / Equity | - | - | 0.02x | 0.02x | 0.03x | 0.02x |
| Interest Coverage | -201.66x | -1514.40x | - | - | - | - |
| FCF Conversion | 1.04x | 0.14x | 0.32x | 0.40x | -3.12x | 1.99x |
| Revenue Growth | - | 80.18% | 82.77% | 93.81% | 65.49% | 69.33% |
Hims & Hers Health, Inc. (HIMS) has a price-to-earnings (P/E) ratio of 58.9x. This suggests investors expect higher future growth.
Hims & Hers Health, Inc. (HIMS) reported $2.21B in revenue for fiscal year 2024. This represents a 2578% increase from $82.6M in 2019.
Hims & Hers Health, Inc. (HIMS) grew revenue by 69.3% over the past year. This is strong growth.
Yes, Hims & Hers Health, Inc. (HIMS) is profitable, generating $133.8M in net income for fiscal year 2024 (8.5% net margin).
Hims & Hers Health, Inc. (HIMS) has a return on equity (ROE) of 30.7%. This is excellent, indicating efficient use of shareholder capital.
Hims & Hers Health, Inc. (HIMS) generated $131.5M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.